Fadi Haddad
- Infectious Diseases top 5%
- Clinical Biochemistry top 2%
- Epidemiology
- Pharmacology
- Public Health, Environmental and Occupational Health
- Co-authors
- George SakoulasMatthew GeriakVictor NizetRavina KullarWarren E. RoseMarcus ZervosKerry L. LaPlantePoochit Nonejuie
- Topics
- COVID-19 Clinical Research Studies (6 papers)Antimicrobial Resistance in Staphylococcus (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Fadi Haddad
10 papers receiving 369 citations
Peers
Comparison fields: 5 of 52
- Infectious Diseases 331
- Clinical Biochemistry 154
- Epidemiology 113
- Pharmacology 72
- Public Health, Environmental and Occupational Health 68
Countries citing papers authored by Fadi Haddad
This map shows the geographic impact of Fadi Haddad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Haddad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Haddad more than expected).
Fields of papers citing papers by Fadi Haddad
This network shows the impact of papers produced by Fadi Haddad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Haddad. The network helps show where Fadi Haddad may publish in the future.
Co-authorship network of co-authors of Fadi Haddad
This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Haddad. A scholar is included among the top collaborators of Fadi Haddad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Haddad. Fadi Haddad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Expanded Clinical Evaluation of the CLUNGENEandreg; Rapid COVID-19 Antibody Test | 1 |
| 2 | 22 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 25 | |
| 6 | 35 | |
| 7 | 65 | |
| 8 | 138 | |
| 9 | 33 | |
| 10 | 47 |
About Fadi Haddad
Fadi Haddad is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology, having authored 10 papers that have together received 373 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Clinical Biochemistry (154 citations), Infectious Diseases (331 citations) and Molecular Medicine (45 citations). Fadi Haddad has collaborated with scholars based in United States and Germany. Frequent co-authors include George Sakoulas, Matthew Geriak, Victor Nizet, Ravina Kullar, Warren E. Rose, Marcus Zervos, Kerry L. LaPlante, Poochit Nonejuie, Joseph Pogliano and Nancy F. Crum‐Cianflone. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.